Get the Stockscreener App
10.35
0.51%
-0.053
Nyxoah Sa stock is traded at $10.35, with a volume of 7,483.
It is down -0.51% in the last 24 hours and down -4.46% over the past month.
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
See More
Previous Close:
$10.40
Open:
$10.35
24h Volume:
7,483
Relative Volume:
0.17
Market Cap:
$387.26M
Revenue:
$4.71M
Net Income/Loss:
$-46.77M
P/E Ratio:
-6.1619
EPS:
-1.6792
Net Cash Flow:
$-60.34M
1W Performance:
-1.74%
1M Performance:
-4.46%
6M Performance:
+22.45%
1Y Performance:
-32.15%
1-Day Range:
$10.30
$10.51
1-Week Range:
$10.30
$10.92
52-Week Range:
$6.76
$20.00
Nyxoah Sa Stock (NYXH) Company Profile
Name
Nyxoah Sa
Sector
Industry
Phone
-
Address
-
Compare NYXH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NYXH
Nyxoah Sa
|
10.35 | 387.26M | 4.71M | -46.77M | -60.34M | -1.6792 |
|
ISRG
Intuitive Surgical Inc
|
591.79 | 211.07B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
227.43 | 65.30B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
90.31 | 44.67B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
231.69 | 34.04B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
88.48 | 17.62B | 3.90B | 392.30M | 288.10M | 1.95 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-31-23 | Initiated | H.C. Wainwright | Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Apr-21-22 | Initiated | Oppenheimer | Outperform |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Dec-21-21 | Resumed | Cantor Fitzgerald | Overweight |
| Jul-28-21 | Initiated | Cantor Fitzgerald | Overweight |
View All
Nyxoah Sa Stock (NYXH) Latest News
(NYXH) On The My Stocks Page - Stock Traders Daily
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East - The Manila Times
Nyxoah (NASDAQ:NYXH) Stock Price Up 0.6%Here's What Happened - MarketBeat
Tri Pointe Homes (TPH) To Report Earnings Tomorrow: Here Is What To Expect - The Globe and Mail
Nyxoah (NASDAQ:NYXH) Shares Up 0.6% – Here’s What Happened - Defense World
Nyxoah to Present at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Environmental Expert
(NYXH) Trading Report - Stock Traders Daily
Trend Tracker for (NYXH) - Stock Traders Daily
Cantor Fitzgerald Predicts Nyxoah FY2025 Earnings - Defense World
NYXHNyxoah SA Ordinary Shares Latest Stock News & Market Updates - StockTitan
Nyxoah Receives Transparency Notification from BlackRock - TipRanks
Publication relating to transparency notifications - GlobeNewswire
BlackRock Reduces Stake in Nyxoah Below 3% Threshold in Latest Holdings Update - StockTitan
Contrasting Nyxoah (NASDAQ:NYXH) and DarioHealth (NASDAQ:DRIO) - Defense World
(NYXH) Proactive Strategies - Stock Traders Daily
Retail investors are Nyxoah S.A.'s (EBR:NYXH) biggest owners and were rewarded after market cap rose by €38m last week - Simply Wall St
Nyxoah (NASDAQ:NYXH) Stock Price Up 1.2% – Here’s What Happened - Defense World
Nyxoah Receives Transparency Notification from BlackRock, Inc. - TipRanks
Nyxoah: The Future Of OSA (NASDAQ:NYXH) - Seeking Alpha
How the (NYXH) price action is used to our Advantage - Stock Traders Daily
BlackRock Takes 3% Stake in Medical Device Maker Nyxoah in Strategic Investment Move - StockTitan
Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024 - Finansavisen
(NYXH) Investment Analysis and Advice - Stock Traders Daily
Nyxoah's SWOT analysis: sleep apnea innovator faces growth hurdles - Investing.com
Nyxoah's SWOT analysis: sleep apnea innovator faces growth hurdles By Investing.com - Investing.com UK
Nyxoah introduces neurostimulator device for sleep apnoea in England - Yahoo Finance
Nyxoah's nerve stimulation device meets endpoints in sleep apnoea studyMedical Device Network - Oficjalny Portal Gminy Brzesko
HC Wainwright Reaffirms “Buy” Rating for Nyxoah (NASDAQ:NYXH) - Defense World
Nyxoah’s Genio Neurostimulator for OSA Launches in England - Sleep Review
Nyxoah's SWOT analysis: sleep apnea innovator's stock poised for US launch - Investing.com
Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England - GlobeNewswire
Nyxoah Announces Commercial Launch of Genio Innovative Therapy in England - Marketscreener.com
Where are the Opportunities in (NYXH) - Stock Traders Daily
Nyxoah Updates Share Capital and Voting Rights - TipRanks
Information on the Total Number of Voting Rights And Shares: Nyxoah - The Korea Bizwire
Information on the total number of voting rights and shares - GlobeNewswire
Objective long/short (NYXH) Report - Stock Traders Daily
Nyxoah (NASDAQ:NYXH) vs. Alpha Tau Medical (NASDAQ:DRTS) Head to Head Contrast - Defense World
Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference - The Korea Bizwire
Nyxoah to Present at Healthcare Conference Amidst Growth - TipRanks
Nyxoah to Present Sleep Apnea Innovation at Piper Sandler Healthcare Conference | NYXH Stock News - StockTitan
Nyxoah SA (NYXH) Reports Q3 Loss, Tops Revenue Estimates - MSN
Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024: Nyxoah - The Korea Bizwire
Nyxoah Schedules Special Meeting to Vote on EIB Loan Agreement Terms | NYXH Stock News - StockTitan
Publication Relating to Transparency Notifications: Nyxoah - The Korea Bizwire
Nyxoah’s Voting Rights Shift with ResMed Stake - TipRanks
ResMed's Stake in Nyxoah Drops Below 5% Threshold in Latest Holdings Update | NYXH Stock News - StockTitan
Publication relating to transparency notifications, Business Wires News - AsiaOne
Nyxoah S.A. (NASDAQ:NYXH) Short Interest Down 17.4% in October - MarketBeat
Nyxoah Sa Stock (NYXH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.09%
0.26%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):